During neoadjuvant chemotherapy | During concurrent chemoradiation | |||
---|---|---|---|---|
Event | Grade 3 | Grade 4 | Grade 3 | Grade 4 |
Hematological | ||||
Leukopenia | 15(46.8%) | 3(9.3%) | 7(21.8%) | 1(3.1%) |
Neutropenia | 6(18.7%) | 18(56.2%) | 2(6.2%) | 4(12.5%) |
Neutropenia fever | 3(9.3%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
Thrombocytopenia | 0(0.0%) | 0(0.0%) | 3(9.3%) | 1(3.1%) |
Anemia | 0(0.0%) | 0(0.0%) | 2(6.2%) | 0(0.0%) |
Non-hematological | ||||
Fatigue | 4(12.5%) | 0(0.0%) | 4(12.5%) | 0(0.0%) |
Nausea/vomiting | 4(12.5%) | 0(0.0%) | 4(12.5%) | 0(0.0%) |
Ototoxicity | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
Diarrhea | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
Liver dysfunction | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
Kidney dysfunction | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
Stomatitis | 1(3.1%) | 0(0.0%) | 8(25%) | 0(0.0%) |
Dermatitis | - | - | 1(3.1%) | 0(0.0%) |
Xerostomia | - | - | 9(28.1%) | 0(0.0%) |